Inventor · disambiguated record
Manjunatha Narayana Rao Kamble
Also filed as: KAMBLE MANJUNATHA NARAYANA RAO
4 granted patents·1 pending application·4 citations·filing 2018–2021
61Inventor score
Files withBRISTOL MYERS SQUIBB CO5
Top patents by PatentIndex Score
5 records- 0188US10669272B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 2, 2020·4 cites·13 claims
- 0267US11713316B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 1, 2023·0 cites·11 claims
- 0361US10954238B1Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 23, 2021·0 cites·11 claims
- 0451US2023089255A1Combinations of dgk inhibitors and checkpoint antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 0543US10961239B2TGF beta receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 30, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Manjunatha Narayana Rao Kamble files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →